Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4560445
Max Phase: Preclinical
Molecular Formula: C67H111N13O19S2
Molecular Weight: 1466.83
Molecule Type: Unknown
Associated Items:
ID: ALA4560445
Max Phase: Preclinical
Molecular Formula: C67H111N13O19S2
Molecular Weight: 1466.83
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O
Standard InChI: InChI=1S/C67H111N13O19S2/c1-4-45(2)61-66(95)76-48(27-28-53(68)82)63(92)77-50(39-54(69)83)64(93)78-51(42-100-37-19-21-57(86)74-49(65(94)79-61)38-46-23-25-47(81)26-24-46)62(91)73-40-58(87)75-52(67(96)80(3)41-55(70)84)43-101-44-59(88)72-30-32-98-34-36-99-35-33-97-31-29-71-56(85)20-17-15-13-11-9-7-5-6-8-10-12-14-16-18-22-60(89)90/h23-26,45,48-52,61,81H,4-22,27-44H2,1-3H3,(H2,68,82)(H2,69,83)(H2,70,84)(H,71,85)(H,72,88)(H,73,91)(H,74,86)(H,75,87)(H,76,95)(H,77,92)(H,78,93)(H,79,94)(H,89,90)/t45-,48-,49-,50-,51-,52-,61-/m0/s1
Standard InChI Key: XJTPPYADCNENDS-JSNGHHEFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1466.83 | Molecular Weight (Monoisotopic): 1465.7561 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Pflimlin E, Zhou Z, Amso Z, Fu Q, Lee C, Muppiddi A, Joseph SB, Nguyen-Tran V, Shen W.. (2020) Engineering a Potent, Long-Acting, and Periphery-Restricted Oxytocin Receptor Agonist with Anorexigenic and Body Weight Reducing Effects., 63 (1): [PMID:31850759] [10.1021/acs.jmedchem.9b01862] |
Source(1):